BioCryst Pharmaceuticals
BCRX
BCRX
230 hedge funds and large institutions have $2.07B invested in BioCryst Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 61 reducing their positions, and 36 closing their positions.
Holders
230
Holders Change
-4
Holders Change %
-1.71%
% of All Funds
3.71%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
34
Increased
93
Reduced
61
Closed
36
Calls
$53M
Puts
$22.5M
Net Calls
+$30.6M
Net Calls Change
-$5.65M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SEC
251
Seven Eight Capital
New York
| – | -$256K | -20,330 | Closed |
|
|
FRM
252
Fox Run Management
Greenwich,
Connecticut
| – | -$250K | -19,854 | Closed |
|
|
GCP
253
GSA Capital Partners
London,
United Kingdom
| – | -$241K | -19,121 | Closed |
|
|
PHK
254
Point72 Hong Kong
Hong Kong
| – | -$232K | -18,428 | Closed |
|
|
HT
255
HAP Trading
New York
| – | -$225K | -17,834 | Closed |
|
256
Los Angeles Capital Management
Los Angeles,
California
| – | -$180K | -14,285 | Closed |
|
|
FAIM
257
Financial Advocates Investment Management
Olympia,
Washington
| – | -$369K | -12,708 | Closed |
|
|
QIM
258
Quantitative Investment Management
Charlottesville,
Virginia
| – | -$134K | -10,677 | Closed |
|
259
Amundi
Paris,
France
| – | -$106K | -7,471 | Closed |
|
|
DFCM
260
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$85K | -6,732 | Closed |
|
261
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$80K | -5,019 | Closed |
|
|
SO
262
STRS Ohio
Columbus,
Ohio
| – | -$18K | -1,500 | Closed |
|
|
BWL
263
Bogart Wealth LLC
Mclean,
Virginia
| – | -$3K | -250 | Closed |
|